Cargando…
Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
Accumulation of advanced glycation endproducts (AGEs) is linked to decline in renal function, particularly in patients with diabetes. Major forms of AGEs in serum are protein-bound AGEs and AGE free adducts. In this study, we assessed levels of AGEs in subjects with and without diabetes, with normal...
Autores principales: | Rabbani, Naila, Adaikalakoteswari, Antonysunil, Larkin, James R., Panagiotopoulos, Sianna, MacIsaac, Richard J., Yue, Dennis K., Fulcher, Gregory R., Roberts, Matthew A., Thomas, Merlin, Ekinci, Elif, Thornalley, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820473/ https://www.ncbi.nlm.nih.gov/pubmed/36613596 http://dx.doi.org/10.3390/ijms24010152 |
Ejemplares similares
-
Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2012) -
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
por: Perkins, Bruce A., et al.
Publicado: (2020) -
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
por: Wetzels, Suzan, et al.
Publicado: (2017) -
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
por: Wetzels, Suzan, et al.
Publicado: (2019) -
Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis
por: Anwar, Attia, et al.
Publicado: (2018)